These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11460569)

  • 1. Pathogenesis of dyslipidemia in type 2 diabetes.
    Taskinen MR
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S180-8. PubMed ID: 11460569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S; Terzi AB; Tousoulis D; Koulouris S
    Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
    Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D
    Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
    Braschi S
    Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hyperlipidemia in diabetes mellitus].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():143-51. PubMed ID: 11347047
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes.
    Rizzo M; Rini GB; Berneis K
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):477-82. PubMed ID: 17853329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
    Vakkilainen J; Mero N; Schweizer A; Foley JE; Taskinen MR
    Diabetes Metab Res Rev; 2002; 18(6):484-90. PubMed ID: 12469362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic dyslipidemia.
    Chahil TJ; Ginsberg HN
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients.
    Petersen M; Pedersen H; Major-Pedersen A; Jensen T; Marckmann P
    Diabetes Care; 2002 Oct; 25(10):1704-8. PubMed ID: 12351465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
    Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S
    Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
    Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
    Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
    Rizzo M; Berneis K; Altinova AE; Toruner FB; Akturk M; Ayvaz G; Rini GB; Spinas GA; Arslan M
    Diabet Med; 2008 Dec; 25(12):1406-11. PubMed ID: 19046238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review 124: Diabetic dyslipidemia: causes and consequences.
    Goldberg IJ
    J Clin Endocrinol Metab; 2001 Mar; 86(3):965-71. PubMed ID: 11238470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.